Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-24 @ 11:20 PM
NCT ID:
NCT01292356
Eligibility Criteria:
Inclusion Criteria:
* Patients older than 18 years
* Patient with histologically proven metastatic colorectal cancer with KRAS wild-type
* Treatment with cetuximab in first line chemotherapy combined with FOLFOX or FOLFIRI
* Patient has signed informed consent
* Patient affiliated to the Social Security
* Prescription of cetuximab in agreement with the Summary of Product Characteristics
Exclusion Criteria:
* Patients aged under 18
* Patients taking immunosuppressive therapy
* Patient having a severe skin disease
* No measurable metastasis
* Patients with a contra-indication of cetuximab: hypersensitivity to cetuximab or to any excipients
* Severe alteration of respiratory or cardiac function or severe coronary disease
* Patients with contra-indication to chemotherapy FOLFOX and FOLFIRI
* Participation in another research protocol
* Patients not affiliated to the Social Security
* Hospitalized patients without consent
* Pregnant or nursing women, women of childbearing age with no effective contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01292356
Study Brief:
Protocol Section:
NCT01292356